Spectrum Wealth Counsel’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$18.6M Buy
22,466
+321
+1% +$267K 2.23% 9
2024
Q4
$17.1M Buy
22,145
+2,895
+15% +$2.4M 2.01% 10
2024
Q3
$17.1M Sell
19,250
-193
-1% -$174K 2.01% 10
2024
Q2
$17.6M Sell
19,443
-680
-3% -$544K 2.23% 10
2024
Q1
$15.7M Buy
20,123
+39
+0.2% +$27.8K 1.92% 9
2023
Q4
$11.7M Buy
+20,084
New +$11.7M 1.62% 11

Other funds holding LLY

Spectrum Wealth Counsel's LLY Position: Q1 2025 in Review

Spectrum Wealth Counsel increased its Eli Lilly (LLY) stake by 1.4% in Q1 2025, buying an estimated $267K and bringing the position to 22,466 shares worth $18.6M. The position accounts for 2.23% of the portfolio, ranked #9.

Spectrum Wealth Counsel first reported a position in LLY in Q4 2023 and has held it in 6 quarters since. 3,919 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • Spectrum Wealth Counsel held 22,466 shares of Eli Lilly worth $18.6M as of Q1 2025.
  • Spectrum Wealth Counsel bought 321 Eli Lilly shares in Q1 2025, an estimated $267K.
  • Eli Lilly made up 2.23% of Spectrum Wealth Counsel's portfolio in Q1 2025, its #9 holding.
  • Spectrum Wealth Counsel first reported a position in Eli Lilly in Q4 2023 and has held it in 6 quarters since.
  • 3,919 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on Spectrum Wealth Counsel's 13F filing for Q1 2025, filed 7 May 2025.